Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016
Authors Tripathy JP
Received 17 November 2017
Accepted for publication 6 March 2018
Published 31 July 2018 Volume 2018:11 Pages 381—387
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Professor Ming-Hui Zou
Jaya Prasad Tripathy1,2
1International Union Against Tuberculosis and Lung Disease, The Union South East Asia Office, New Delhi, India; 2International Union Against Tuberculosis and Lung Disease, Paris, France
Background: Diabetes, hyperglycemia, and their complications are a growing problem in India. However, no comprehensive picture of this disease burden has yet been presented to date.
Methods: I used aggregate data from the Global Burden of Disease 2016 to describe the burden of diabetes and its risk factors, chronic kidney disease (CKD) due to diabetes, and diseases caused by high fasting plasma glucose from 1990 to 2016 in India.
Results: Deaths due to diabetes accounted for 3.1% (95% uncertainty interval [UI]: 2.9–3.3) of all deaths in India in 2016, up from 0.98% (95% UI: 0.87–1.1) of all deaths in 1990. Diabetes and hyperglycemia accounted for 27.5 million disability-adjusted life years in 2016, of which diabetes accounted for 10 million. Diabetes contributes to the causation of ischemic heart disease, stroke, CKD, peripheral artery disease, specific cancers, and tuberculosis via intermediate hyperglycemia. High body mass index, dietary factors (diet low in fruits, nuts and seeds, and whole grains), and tobacco use were the most important risk factors for diabetes.
Conclusion: Diabetes and CKD due to hyperglycemia pose a large and increasing burden in India. Urgent programs and policies are needed to reduce the identified risk factors for diabetes and its burden.
Keywords: diabetes, hyperglycemia, mortality, morbidity, chronic kidney disease, ischemic heart disease, tuberculosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]